SCHEMBL6018447

SCHEMBL6018447

CS(=O)(=O)OCCCCOC1CCC(CNCS(=O)(=O)c2ccc(Cl)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
PKM P14618 1/20 0.40
PSEN1 P49768 4/20 0.39
PSEN2 P49810 4/20 0.39
APH1B Q8WW43 4/20 0.39
NCSTN Q92542 4/20 0.39
APH1A Q96BI3 4/20 0.39
PSENEN Q9NZ42 4/20 0.39
LMNA P02545 3/20 0.38
THRB P10828 2/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPK1 P28482 1/20 0.35
CXCR3 P49682 2/20 0.34
TAS2R14 Q9NYV8 1/20 0.33
GAA P10253 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6018945 0.81 ALDH1A1 (0.38) ALDH1A1PKMLMNATHRBMEN1
SCHEMBL6018986 0.77 LMNA (0.41) ALDH1A1PKMPSEN1PSEN2APH1B
SCHEMBL6018451 0.77 LMNA (0.41) ALDH1A1PKMPSEN1PSEN2APH1B
SCHEMBL6018455 0.77 LMNA (0.41) ALDH1A1PKMPSEN1PSEN2APH1B
SCHEMBL6018955 0.72 LSS (0.41) LMNASMN1; SMN2TAS2R14
SCHEMBL6018951 0.72 LSS (0.41) LMNASMN1; SMN2TAS2R14
SCHEMBL31495674 0.69 TSHR (0.56) ALDH1A1LMNATSHRMAPK1NPC1
SCHEMBL6018421 0.67 LMNA (0.42) ALDH1A1PKMPSEN1PSEN2APH1B
SCHEMBL6018417 0.67 LMNA (0.42) ALDH1A1PKMPSEN1PSEN2APH1B
SCHEMBL6018802 0.67 LMNA (0.42) ALDH1A1PKMPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1456171-B1 SUBSTITUTED CYCLOHEXANE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-12-20 EP disclosed
US-20050272774-A1 Substituted cyclohexane derivatives ACKERMANN JEAN 2005-12-08 US disclosed
US-6953806-B2 Substituted cyclohexane derivatives HOFFMANN-LA ROCHE INC. (US) 2005-10-11 US disclosed
EP-1456171-A1 SUBSTITUTED CYCLOHEXANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-09-15 EP disclosed
US-20030199550-A1 Substituted cyclohexane derivatives F.HOFFMANN-LA ROCHE AG (CH) 2003-10-23 US disclosed
WO-2003053919-A1 SUBSTITUTED CYCLOHEXANE DERIVATIVES F. HOFFMANN-LA-ROCHE AG (CH) 2003-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272774-A1 Substituted cyclohexane derivatives LSS, CYP51A1, CYP8B1 ALDH1A1 629/4885PKM 2931/4885PSEN1 1857/4885
US-20030199550-A1 Substituted cyclohexane derivatives CYP51A1, LSS, CYP46A1 ALDH1A1 498/4885PKM 2924/4885PSEN1 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.